Skip to content

Ardelyx ARDX Operating Income

Operating Income at other companies

Amgen logo
AmgenAMGN
$2.67B+126%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$950M-444%
AbbVie logo
AbbVieABBV
$3.99B+6.9%
XER
Xeris Biopharma Holdings, Inc.XERS
$7.92M+356%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$193.4M+719%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$41.42M+89.6%

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+25.5%
Enterprise value$1.71B+27.1%
P/S3.6×+0.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's operating income?
Ardelyx (ARDX) reported operating income of -$32.79M in Q1 2026.
How has Ardelyx's operating income changed year-over-year?
Ardelyx's operating income increased by 9.8% year-over-year, from -$36.35M to -$32.79M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.